FATE

FATE THERAPEUTICS INC

FATE·31189P102·US·Common Stock·Healthcare - Biotechnology-Activist

FATE (FATE THERAPEUTICS INC) is held by 88 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($12.1M), VANGUARD CAPITAL MANAGEMENT LLC ($5M), VANGUARD PORTFOLIO MANAGEMENT LLC ($5M). Net institutional sentiment: Mixed.

88
Holders
Avg rating(25 Elite)
$56.8M
Total Value
60% (93)
Fund Consensus
47 buying - 31 selling
FATESmart Money Verdict
View all
Held by 88 funds
25 elite
Who's Trading
ActivistBlackRock, Inc.BlackRock, Inc.1.9%Jul 8, 2026
InsiderTCTAHL CINDYExercise 44K shMay 6, 2026
InsiderTCTAHL CINDYExercise 122K shMay 6, 2026
InsiderESEPSTEIN ROBERT SExercise 25K shMay 5, 2026
InsiderRHRASTETTER WILLIAM HExercise 25K shMay 5, 2026
ActivistRERedmile Group, LLC14.9%Apr 22, 2026
ActivistThe Vanguard GroupThe Vanguard Group0.0%Mar 26, 2026
InsiderTCTAHL CINDYSell $11KJan 9, 2026
InsiderVBValamehr BahramSell $6KJan 9, 2026
ActivistTHE GOLDMAN SACHS GROUP, INC.THE GOLDMAN SACHS GROUP, INC.2.0%Aug 14, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Decreased
10.1M(-1.1%)$12.1M0.0%+92.18%
0
New
4.2M$5M0.0%+126.28%
37
New
4.1M$5M0.0%+126.28%
37
Increased
3.5M(+99.9%)$4.2M0.0%+113.88%
43
Increased
3M(+158.3%)$3.6M0.0%+148.72%
43
Increased
3M(+26.0%)$3.6M0.0%+189.23%
33
Increased
2.6M(+5.0%)$3.1M0.0%-83.79%
28
Decreased
2.3M(-0.1%)$2.7M0.0%-46.63%
0
Increased
1.8M(+351.4%)$2.2M0.0%+106.56%
42
Decreased
1.3M(-7.5%)$1.6M0.0%+92.81%
0
Increased
942,926(+25.8%)$1.1M0.0%-48.21%
31
Decreased
883,790(-44.0%)$1.1M0.0%-25.86%
0
Increased
811,920(+10.8%)$974,3050.0%-72.08%
28
Decreased
767,748(-16.3%)$921,2980.0%-0.06%
0
Decreased
756,273(-3.6%)$907,5280.0%-85.65%
0
New
653,761$784,5130.0%+126.28%
34
Decreased
646,979(-23.2%)$776,3750.0%+172.94%
0
Increased
469,785(+322.4%)$563,7420.0%+142.62%
39
Increased
430,073(+64.7%)$516,0880.0%+171.12%
35
Increased
389,169(+6.7%)$467,0030.0%+143.73%
26

Showing 1-20 of 93

1 / 5

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used